Fengliao Changweikang for Diarrhea-predominant Irritable Bowel Syndrome: N-of-1 Trial

Clinical trial NCT07061184 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07061184
Sponsor: Peking Union Medical College Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Irritable Bowel Syndrome - Diarrhoea Traditional Chinese Medicine (TCM)N of 1 Study Design Efficacy and Safety

Start date: 2025-11-01
Primary completion: 2027-11-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.